16879-40-6 Usage
Uses
Used in Pharmaceutical Industry:
4,6-Dimethyl-2-iodopyrimidine serves as a crucial intermediate in the synthesis of various pharmaceuticals. Its unique structure contributes to the development of new drugs, making it an essential component in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4,6-Dimethyl-2-iodopyrimidine is utilized as an intermediate in the production of pesticides and other agrochemicals, highlighting its versatility in chemical synthesis for different applications.
Used in Dye Production:
4,6-Dimethyl-2-iodopyrimidine is also employed in the manufacturing process of dyes, capitalizing on its chemical properties to create a range of colorants used in various industries.
Used in Organic Compounds Synthesis:
Beyond its applications in pharmaceuticals, agrochemicals, and dyes, 4,6-Dimethyl-2-iodopyrimidine is a valuable precursor in the synthesis of other organic compounds, demonstrating its broad utility in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 16879-40-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,8,7 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 16879-40:
(7*1)+(6*6)+(5*8)+(4*7)+(3*9)+(2*4)+(1*0)=146
146 % 10 = 6
So 16879-40-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H7IN2/c1-4-3-5(2)9-6(7)8-4/h3H,1-2H3
16879-40-6Relevant academic research and scientific papers
Vlad, Gabor,Horvath, Istvan T.
, p. 6550 - 6552 (2002)
A high-yield synthesis was developed for the preparation of 2,2′-bipyrimidine (1) using the Ullmann coupling of 2-iodopyrimidine. The new procedure was also used for the preparation of 4,4′,6,6′-tetramethyl-2,2′-bipyrimidine (2) and 5,5′-dibromo-2,2′-bipyrimidine (3).
RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 38, (2010/04/23)
Compounds of Formulas (I), (IIA) and (IIIA) are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formulas (I), (IIA) and (IIIA) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.